Recro Pharma, Inc.
REPH
NASDAQ Capital Market2.09
USD
-0.01
- -
Total Valuation
Recro Pharma, Inc. carries a market capitalization of 177.42M, placing it among publicly traded companies globally.
| Market Cap | 177.42M |
| Enterprise Value | N/A |
Stock Price Statistics
Recro Pharma, Inc.'s stock has gained approximately 19.42857% over the past 52 weeks. The 50-day moving average sits at 1.73, while the 200-day moving average is 1.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | 19.42857% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.87 |
| Average Volume (20 Days) | N/A |
Stock Splits
Recro Pharma, Inc.'s most recent stock split took place on November 22, 2019 with a 200:223 split ratio.
| Last Split Date | 11/22/2019 |
| Split Ratio | 200:223 |